Back

BMC Infectious Diseases

110 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Novel Risk Factors for Predicting Immune Effector Cell-Associated Neurotoxicity Syndrome
2025-01-17 neurology 10.1101/2025.01.17.25320737
#1 (18.2%)
Show abstract

Withdrawal StatementThe authors have withdrawn this manuscript because of updates to the original manuscript. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

2
Clinical and immunometabolic profiles of overweight and obese patients with dengue: A matched cohort study
2025-12-16 infectious diseases 10.64898/2025.12.15.25342260
#1 (14.0%)
Show abstract

BackgroundObesity is a risk factor for severe dengue, but underlying mechanisms remain unclear. This study compared clinical features, outcomes, and biomarkers between overweight/obese and healthy-weight patients with dengue infection. MethodsWe conducted an observational matched cohort study (2019-2022) including 75 overweight/obese patients and 75 matched healthy-weight patients with dengue (by age, sex, illness phase, and inpatient ward). The primary clinical outcome was overall severity per...

3
Correlation between the NRS-2002 score and PD-1/CTLA-4 levels in patients with CAP
2025-02-21 emergency medicine 10.1101/2025.02.19.25322531
#1 (12.8%)
Show abstract

ObjectiveTo investigated the relationship between nutritional status and PD-1/CTLA-4 in CAP patients to determine whether the nutritional status is associated with the immunosuppression generated by T cells. MethodsAccording the enrollment strategy, we enrolled 60 patients and collected their medical records.Take their blood samples and analyzed the distribution of PD-1 and CTLA-4 in different T cell subgroups. ResultsThe level of PD-1 and CTLA-4 in the CD4+, CD8+ and Tregs were inclusive with...

4
Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population
2020-03-10 infectious diseases 10.1101/2020.03.08.20031229
#1 (11.7%)
Show abstract

In December 2019, novel coronavirus (SARS-CoV-2) infected pneumonia occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in Chinese Han population is limited. Our objective is to describe the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in the Chinese Han population. In this case series of 752 patients, the full spectrum of cases is described. Fever w...

5
Characteristics of lymphocyte subsets and their predicting values for the severity of COVID-19 patients
2020-05-05 infectious diseases 10.1101/2020.05.01.20086421
#1 (11.5%)
Show abstract

Severe COVID-19 patients showed worse clinical outcomes compared to mild and moderate patients. However, effective indicators are still lacking to predict the severity of the disease. In the present study, we retrospectively analyzed the clinical and laboratory data of 16 COVID-19 patients and found that the absolute counts of three T-cells (CD3+, CD4+, and CD8+) were significantly lower in the moderate and severe patients than those in mild patients and were significantly lower in severe patien...

6
Sex-based clinical and immunological differences in COVID-19
2020-09-01 infectious diseases 10.1101/2020.08.29.20126201
#1 (11.2%)
Show abstract

BackgroundMales and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take sex as consideration. MethodsWe performed an unbiased sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and SARS-CoV-2 specific antibody levels of 1,558 males and 1,499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow cytometry. Total antibody, Spike...

7
Association of IFNAR2 rs2236757 and OAS3 rs10735079 polymorphisms with susceptibility to COVID-19 infection and severity
2022-09-27 infectious diseases 10.1101/2022.09.27.22280425
#1 (10.2%)
Show abstract

The clinical course and severity of COVID-19 vary among patients. This study aimed to investigate the association of the interferon receptor (IFNAR2) rs2236757 and oligoadenylate synthetase 3 (OAS3) rs10735079 gene polymorphisms with risk of COVID-19 infection and severity among Palestinian patients. The study was conducted between April and May 2021 on 154 participants that divided into three groups: the control group (RT-PCR-negative, n=52), the community cases group (RT-PCR-positive, n= 70) a...

8
The burden trend and risk factors of multiple myeloma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
2025-04-21 epidemiology 10.1101/2025.04.20.25326120
#1 (8.7%)
Show abstract

IMPORTANCEMM was an incurable clonal plasma cell malignancy with substantial prevalence and incidence, which had resulted in a significant burden of disease. Our study aimed to evaluate the global, regional and national burden of MM by sex, age, and SDI from 1990 to 2021, along with associated risk factors and predicted temporal trends. OBJECTIVETo assess the global burden, epidemiological trends, and risk factors of MM and project its incidence rate by 2050. DesignThis is a systematic analysi...

9
Evaluation of lymphocyte subtypes in COVID-19 patients
2021-07-16 infectious diseases 10.1101/2021.07.12.21260382
#1 (8.7%)
Show abstract

BackgroundAlthough the many aspects of COVID-19 have not been yet recognized, it seems that the dysregulation of the immune system has a very important role in the progression of the disease. In this study the lymphocyte subsets were evaluated in COVID-19 patients with different severity. MethodsIn this prospective study, the levels of peripheral lymphocyte subsets (CD3+, CD4+, CD8+ T cells; CD19+ and CD20+ B cells; CD16+/CD56+ NK cells, and CD4+/CD25+/FOXP3+ regulatory T cells) were measured i...

10
Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)
2020-02-12 hematology 10.1101/2020.02.10.20021832
#1 (7.9%)
Show abstract

BackgroundTo explore the cellular immunity and cytokines status of NCP patients and to predict the correlation between the cellular immunity levels, cytokines and the severity of patients. Methods123 NCP patients were divided into mild and severe groups. Peripheral blood was collected, lymphocyte subsets and cytokines were detected. Correlation analysis was performed on the lymphocyte subsets and cytokines, and the differences between the indexes of the two groups were analyzed. Results102 mil...

11
Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 82 studies comprising 58 cytokines/chemokines/growth factors.
2024-02-08 infectious diseases 10.1101/2024.02.08.24302516
#1 (7.5%)
Show abstract

BackgroundMultiple studies have shown that Long COVID (LC) disease is associated with heightened immune activation, as evidenced by elevated levels of inflammatory mediators. However, there is no comprehensive meta-analysis focusing on activation of the immune inflammatory response system (IRS) and the compensatory immunoregulatory system (CIRS) along with other immune phenotypes in LC patients. ObjectivesThis meta-analysis is designed to explore the IRS and CIRS profiles in LC patients, the in...

12
Celebrex adjuvant therapy on COVID-19: An experimental study
2020-05-11 public and global health 10.1101/2020.05.05.20077610
#1 (7.4%)
Show abstract

BackgroundThe world is under serious threat with the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19). However, there is no effective drug for the treatment of COVID-19. Based on analyses of available data, we deduced that the excessive prostaglandins E2 (PGE2) accumulation mediated by cyclooxygenase-2 (COX-2) was the key pathological basis of COVID-19. MethodsThe urine PGE2 levels were measured by mass spectrometry...

13
Apolipoprotein A1 levels and its association with NS1 in the pathogenesis of acute dengue
2022-07-22 infectious diseases 10.1101/2022.07.20.22277834
#1 (7.4%)
Show abstract

BackgroundThe dengue NS1 antigen is a secretory protein and was shown to associate with apolipoprotein A1 (ApoA1). Therefore, we sought to investigate the changes in ApoA1 levels in patients with varying severity of acute dengue and then proceeded to investigate how ApoA1 and NS1 interactions affect cytokine production from primary human monocytes. Methodology/Principal FindingsSerial measurements of ApoA1, viral loads, NS1 antigen levels and lipid profiles were done in adult patients with deng...

14
Serum neopterin levels in relation to mild and severe COVID-19
2020-08-22 infectious diseases 10.1101/2020.08.19.20178178
#1 (7.3%)
Show abstract

BackgroundThe COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is rapidly spreading worldwide. There is limited information about prognostic markers that could help clinicians to identify COVID-19 patients with a poor prognosis. Serum levels of the immune activation marker neopterin has shown to be of prognostic value in patients with SARS. The aim of this study was to investigate whether serum neopterin is associated with the severity of COVID-19. MethodsWe included 34 patients with co...

15
Potential Factors for Prediction of Disease Severity of COVID-19 Patients
2020-03-23 infectious diseases 10.1101/2020.03.20.20039818
#1 (7.3%)
Show abstract

ObjectiveCoronavirus disease 2019 (COVID-19) is an escalating global epidemic caused by SARS-CoV-2, with a high mortality in critical patients. Effective indicators for predicting disease severity in SARS-CoV-2 infected patients are urgently needed. MethodsIn this study, 43 COVID-19 patients admitted in Chongqing Public Health Medical Center were involved. Demographic data, clinical features, and laboratory examinations were obtained through electronic medical records. Peripheral blood specimen...

16
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
2020-03-03 infectious diseases 10.1101/2020.03.01.20029074
#1 (7.2%)
Show abstract

BackgroundCoronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease severity and prognosis is urgently needed. MethodsDynamic changes of blood lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients were retrospectively analyzed. A Time-LYM% model (TLM) was established according to the descriptive studies and was validated in 92 hospital...

17
Thyroid function abnormalities in COVID-19 patients
2020-06-16 endocrinology 10.1101/2020.06.15.20130807
#1 (7.1%)
Show abstract

BackgroundThe novel coronavirus COVID-19, has caused a worldwide pandemic, impairing several human organs and systems. Whether COVID-19 affects human thyroid function remains unknown. Methods84 hospitalized COVID-19 patients in the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China) were respectively enrolled in this study. In addition, 91 other patients with pneumonia and 807 healthy subjects were included as controls. FindingsWe found that the levels of TT3 an...

18
Viral shedding and immunological features of children COVID-19 patients
2020-08-31 infectious diseases 10.1101/2020.08.25.20181446
#1 (7.0%)
Show abstract

BackgroundSARS-CoV-2 could infect people at all ages, and the viral shedding and immunological features of children COVID-19 patients were analyzed. MethodsEpidemiological information and clinical data were collected from 35 children patients. Viral RNAs in respiratory and fecal samples were detected. Plasma of 11 patients were collected and measured for 48 cytokines. Results40% (14/35) of the children COVID-19 patients showed asymptomatic infections, while pneumonia shown by CT scan occurred ...

19
COVID-19 gender difference pattern in Iranian population, compared to the global pattern; a systematic review and meta-analysis
2021-05-25 infectious diseases 10.1101/2021.05.23.21257692
#1 (7.0%)
Show abstract

The coronavirus disease 2019 (COVID-19) pandemic has highlighted Sex-related immune responses. In this review, gender differences in seroprevalence, severity, mortality, and recovery in the Iranian population were systematically compared to the COVID-19 global pattern. This compressive meta-analysis was conducted on studies published up to April 1, 2021, examining seroprevalence in the general population as well as disease outcomes in hospitalized patients. Data were analyzed based on gender to ...

20
Circulating cytokines and lymphocyte subsets in patients who have recovered from COVID-19
2020-07-24 infectious diseases 10.1101/2020.07.22.20160259
#1 (6.7%)
Show abstract

To investigate the immune status of people who previously had COVID-19 infections, we recruited patients 2 weeks post-recovery and analyzed circulating cytokines and lymphocyte subsets. We measured levels of total lymphocytes, CD4+ T cells, CD8+ T cells, CD19+ B cells, CD56+ NK cells, and the serum concentrations of interleukin (IL)-1, IL-4, IL-6, IL-8, IL-10, transforming growth factor beta (TGF-{beta}), tumor necrosis factor alpha (TNF-), and interferon gamma (IFN-{gamma}) by flow cytometry. W...